from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2327/-

LFCtreatmentdescriptionclass of inhibitor

-0.189

Amikacinug/mL Amikacintranslation

-0.500

Cap5-10ug/mL Capreomycintranslation

0.450

Rox10-50 ug/mL Roxithromycintranslation

0.522

SM2-5 ug/mL Streptomycintranslation

0.334

Tet5-10 ug/mL Tetracyclinetranslation

-1.461

Rif0.2-5ug/mL Rifampicintranscription

-1.126

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.061

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.087

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.610

CPZ10-50 ug/mL Chlorpromazinerespiration

0.244

Clofazimine10-13 ug/mL Clofaziminerespiration

0.432

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.874

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.102

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

2.691

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.193

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.371

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.929

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.972

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

2.275

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.674

KCN5-20 ug/mL Potassium cyaniderespiration

1.085

NaN30.2-2 mM Sodium aziderespiration

-1.674

Nigericin50 uM Nigericinrespiration

-0.683

TRC10-150 ug/mL Triclosanrespiration

-0.729

TRZ10-25 ug/mL Thioridazinerespiration

2.201

Valinomycin0.5-10 uM Valinomycinrespiration

0.100

ZnSO42 mM ZnSO4respiration

1.563

menadione6-10 ug/mL Menadionerespiration

0.266

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.397

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.131

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.240

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.666

NRP_1Non-replicating persistence stage 1dosRassociated

0.177

Amp0.2mg/mL AmpicillincellWall

-0.113

Cephalexin20-100 ug/mL CephalexincellWall

0.476

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.343

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.342

EMB10-20 ug/mL EthambutolcellWall

-0.256

Eta12-40 ug/mL EthionamidecellWall

-0.064

INH0.2-0.4 ug/mL IsoniazidcellWall

0.579

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.165

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.602

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.625

BZA0.12 mg/mL BenzamidearomaticAmides

-0.478

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.488

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.098

H2O24 mM hydrogen peroxideDNAdamaging

-0.759

Levo10 ug/mL LevofloxacinDNAdamaging

-0.688

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.843

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.313

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.776

UVUV-irradiationDNAdamaging

-0.271

ARP41-4 ug/mL Antitubercular compound ARP4?

0.039

Antimycin12.5-50 ug/mL Antimycin A?

0.491

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.551

PA_110-50 ug/mL Antitubercular compound PA-1?

0.234

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.380

PA8240.2-2 ug/mL PA-824?

0.978

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.686

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.080

Verapamil50 uM Verapamil?

1.213

mercaptoethanol2 mM 2-Mercaptoethanol?

0.253

methoxatin10-20 ug/mL Methoxatin?